tiprankstipranks
Trending News
More News >
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market
Advertisement

Lyra Therapeutics (LYRA) Technical Analysis

Compare
367 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Lyra Therapeutics’s (LYRA) Moving Averages Convergence Divergence (MACD) indicator is -0.30, suggesting Lyra Therapeutics is a Sell.
Lyra Therapeutics’s (LYRA) 20-Day exponential moving average is 7.28, while Lyra Therapeutics’s (LYRA) share price is $7.19, making it a Sell.
Lyra Therapeutics’s (LYRA) 50-Day exponential moving average is 7.99, while Lyra Therapeutics’s (LYRA) share price is $7.19, making it a Sell.

Lyra Therapeutics (LYRA) Pivot Points

Aug 28, 2025, 10:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.69
6.79
6.99
7.09
7.29
7.39
7.59
Fibonacci
6.79
6.90
6.97
7.09
7.20
7.28
7.39
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lyra Therapeutics (LYRA) Moving Averages

Aug 28, 2025, 10:57 AM
Period
Simple
Exponential
MA5
7.19Sell
7.13Sell
MA10
7.17Sell
7.14Sell
MA20
6.98Buy
7.28Sell
MA50
8.33Sell
7.99Sell
MA100
8.14Sell
8.47Sell
MA200
8.82Sell
9.25Sell
Lyra Therapeutics’s (LYRA) 10-Day exponential moving average is 7.14, while Lyra Therapeutics’s (LYRA) share price is $7.19, making it a Sell.
Lyra Therapeutics’s (LYRA) 100-Day exponential moving average is 8.47, while Lyra Therapeutics’s (LYRA) share price is $7.19, making it a Sell.
Lyra Therapeutics’s (LYRA) stock price is $7.19 and Lyra Therapeutics’s (LYRA) 50-day simple moving average is 8.33, creating a Sell signal.
Lyra Therapeutics’s (LYRA) stock price is $7.19 and Lyra Therapeutics’s (LYRA) 100-day simple moving average is 8.14, creating a Sell signal.
Lyra Therapeutics’s (LYRA) stock price is $7.19 and Lyra Therapeutics’s (LYRA) 200-day simple moving average is 8.82, creating a Sell signal.

Lyra Therapeutics (LYRA) Technical Indicators

Aug 28, 2025, 10:57 AM
Name
Value
Implied Action
RSI (14)
43.74
Neutral
STOCH (9,6)
34.35
Neutral
STOCHRSI (14)
50.13
Neutral
MACD (12,26)
-0.30
Sell
ADX (14)
9.01
Buy
Williams %R
-52.07
Buy
CCI (14)
45.46
Neutral
ATR (14)
0.58
-
Ultimate Oscillator
52.54
Neutral
ROC
1.89
Buy
Lyra Therapeutics’s (LYRA) Relative Strength Index (RSI) is 43.74, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Trend Strength Indicator (ADX) is 9.01, creating a Buy signal.
Lyra Therapeutics’s (LYRA) Commodity Channel Index (CCI) is 45.46, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Price Rate of Change (ROC) is 1.89, creating a Buy signal.

FAQ

Is LYRA a Buy, Hold, or Sell?
Based on LYRA’s technical indicators, LYRA is a Sell.
    What is LYRA’s RSI (14)?
    LYRA’s RSI (14) is 43.74, which suggests LYRA is a Neutral.
      What is LYRA’s MACD?
      LYRA’s MACD is -0.30, which suggests LYRA is a Sell.
        What is LYRA’s 5-day moving average?
        LYRA’s 5-day moving average is 7.19, which suggests LYRA is a Sell.
          What is LYRA’s 20-day moving average?
          LYRA 20-day moving average is 6.98, which suggests LYRA is a Buy.
            What is LYRA’s 50-day moving average?
            LYRA’s 50-day moving average is 8.33, which suggests LYRA is a Sell.
              What is LYRA’s 200-day moving average?
              LYRA’s 200-day moving average is 8.82, which suggests LYRA is a Sell.
                What is LYRA’s Williams % R (14)?
                LYRA’s Williams % R (14) is -52.07, which suggests LYRA is a Buy.
                  What is LYRA’s CCI (14)?
                  LYRA’s CCI (14) is 45.46, which suggests LYRA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis